Dew, With all the buyouts lately, it might be interesting to start compiling a list of potential / likely bio buyout candidates. Looks like foreign companies are using the weak dollar to their advantage. Do you see other likely targets in the generic space? Thanks.
Market Data 
Markets 
AI
